Swiss Biotech Day 2025 is a premier biotechnology conference offering a platform for networking, idea exchange, and exploring advancements in R&D, manufacturing, data management, AI, and innovative financing.
Citeline is a proud main sponsor of this event, and we invite you to visit us at booth #34.
Swiss Biotech Day 2025 is a premier global event bringing together over 2,500 professionals from the biotech, pharmaceutical, and life sciences sectors worldwide. The conference serves as a dynamic platform for networking, showcasing the latest innovations, and fostering collaboration between startups, established companies, and international delegations. Attendees can expect opportunities for in-depth discussions, investment partnerships, and insights into the most recent trends shaping the future of biotech.
This event features an exhibition, thematic sessions, and one-on-one partnering meetings, making it an ideal venue for exchanging ideas, promoting new technologies, and advancing the biotechnology ecosystem. With a focus on fostering growth, Swiss Biotech Day helps strengthen Switzerland's position as a global leading hub for biotech innovation.
Book a meeting with us on HelloPartnering, an online conference platform that allows delegates to contact other participants and schedule meetings with them.
Agenda
MAY 05, 2025
8am
CET
Biopharma Deal-Making Roundup & Panel Discussion: Is Partnership the Route to Success?
08:00 AM - 09:45 AM CET
The exclusive pre-conference breakfast networking and panel discussion, hosted by Citeline and the Swiss Biotech Association, is by invitation only.
Daniel Chancellor
•
VP of Thought Leadership, Norstella
Kevin Grogan
•
Managing Editor, Scrip, Citeline
Our experts
Daniel Chancellor
VP of Thought Leadership
Norstella
Kevin Grogan
Managing Editor, Scrip
Citeline
Daniel Chancellor
VP of Thought Leadership
Norstella
Daniel has more than 15 years of experience in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. Beginning his advisory career at Citeline, Daniel now oversees the thought leadership program for Norstella and its constituent companies, producing materials that support clients across a range of hot topics in the biopharma industry. As part of this, Daniel regularly participates in webinars, conferences, and other speaking arrangements, and he has provided expert insights across a wide range of leading industry and business publications.
Kevin Grogan
Managing Editor, Scrip
Citeline
Kevin Grogan has extensive experience across all areas of the pharmaceutical industry and therapeutic sectors, having interviewed numerous key leaders in the biopharma and biotech spaces. A regular participant and moderator at financial and medical conferences, he brings valuable insights into the discussions shaping the future of the industry. Kevin has also shared his expertise on BBC television and radio, ITV, and Channel 4, providing thought leadership on the latest trends and breakthroughs in the pharmaceutical and biotech sectors.
